Analysts Offer Predictions for Becton Dickinson and Co’s FY2018 Earnings (BDX)

Becton Dickinson and Co (NYSE:BDX) – Research analysts at William Blair issued their FY2018 earnings estimates for shares of Becton Dickinson and in a research report issued on Tuesday. William Blair analyst B. Weinstein anticipates that the medical instruments supplier will earn $10.85 per share for the year. William Blair also issued estimates for Becton Dickinson and’s FY2019 earnings at $12.50 EPS.

Becton Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Tuesday, February 6th. The medical instruments supplier reported $2.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.41 by $0.07. Becton Dickinson and had a net margin of 2.71% and a return on equity of 16.19%. The business had revenue of $3.08 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same quarter in the prior year, the company posted $2.33 EPS. The firm’s revenue for the quarter was up 5.4% compared to the same quarter last year.

A number of other equities research analysts also recently weighed in on BDX. Zacks Investment Research raised Becton Dickinson and from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Wells Fargo & Co reissued a “positive” rating and issued a $235.00 price target (up previously from $225.00) on shares of Becton Dickinson and in a report on Tuesday, October 24th. They noted that the move was a valuation call. Royal Bank of Canada reissued a “hold” rating and issued a $210.00 price target on shares of Becton Dickinson and in a report on Wednesday, October 25th. Morgan Stanley boosted their price target on shares of Becton Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a report on Friday, November 3rd. Finally, Stifel Nicolaus reissued a “buy” rating and issued a $245.00 price target on shares of Becton Dickinson and in a report on Friday, November 3rd. Four investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $237.27.

Becton Dickinson and (NYSE:BDX) traded down $0.04 during mid-day trading on Friday, reaching $211.40. The company had a trading volume of 986,609 shares, compared to its average volume of 1,622,954. Becton Dickinson and has a fifty-two week low of $175.66 and a fifty-two week high of $248.39. The firm has a market capitalization of $59,084.54, a P/E ratio of 161.61, a PEG ratio of 1.58 and a beta of 1.12. The company has a current ratio of 1.54, a quick ratio of 5.03 and a debt-to-equity ratio of 1.04.

Institutional investors have recently bought and sold shares of the company. Shell Asset Management Co. purchased a new position in Becton Dickinson and in the fourth quarter valued at about $11,069,000. Arizona State Retirement System boosted its stake in Becton Dickinson and by 34.1% in the fourth quarter. Arizona State Retirement System now owns 109,595 shares of the medical instruments supplier’s stock valued at $23,460,000 after acquiring an additional 27,847 shares during the last quarter. Trexquant Investment LP boosted its stake in Becton Dickinson and by 502.2% in the fourth quarter. Trexquant Investment LP now owns 26,131 shares of the medical instruments supplier’s stock valued at $5,594,000 after acquiring an additional 21,792 shares during the last quarter. Pinebridge Investments L.P. purchased a new position in Becton Dickinson and in the fourth quarter valued at about $305,000. Finally, State of Wisconsin Investment Board boosted its stake in Becton Dickinson and by 47.3% in the fourth quarter. State of Wisconsin Investment Board now owns 239,910 shares of the medical instruments supplier’s stock valued at $51,355,000 after acquiring an additional 77,075 shares during the last quarter. Institutional investors own 75.68% of the company’s stock.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 30th. Investors of record on Friday, March 9th will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date is Thursday, March 8th. Becton Dickinson and’s payout ratio is presently 229.01%.

COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2018/02/09/analysts-offer-predictions-for-becton-dickinson-and-cos-fy2018-earnings-bdx.html.

About Becton Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Earnings History and Estimates for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply